AntriaBio names Hoyoung Huh as chair of company's scientific advisory board

AntriaBio names Hoyoung Huh as chair of company's scientific advisory board

LOUISVILLE - AntriaBio Inc. (OTCQB: ANTB), a biopharmaceutical corporation focused on developing novel extended release therapies, announced Dr. Hoyoung Huh , one of the company's... Read More

By: InnovatioNews Monday January 12, 2015 0 comments Tags: AB101, AntriaBio, diabetes, Hoyoung Huh, Louisville, Nevan Elam

AntriaBio raises $7M in private placement transaction, collects $18M in total 2014 investment

AntriaBio raises $7M in private placement transaction, collects $18M in total 2014 investment

LOUISVILLE - AntriaBio Inc. (OTCQB: ANTB), a biopharaceutical corporation focused on developing novel extended release therapies, announced it recently raised approximately $7 million in a... Read More

By: InnovatioNews Friday January 9, 2015 0 comments Tags: AB101, AntriaBio, diabetes, Louisville, Nevan Elam

AntriaBio announces successful tests for AB101 once-weekly basal insulin diabetes treatment

AntriaBio announces successful tests for AB101 once-weekly basal insulin diabetes treatment

LOUISVILLE - AntriaBio Inc. (OTCQB: ANTB), a biopharmaceutical corporation focused on developing novel extended-release therapies, announced it has successfully completed a series of in-vitro... Read More

By: InnovatioNews Thursday January 8, 2015 0 comments Tags: AB101, AntriaBio, Brian Roberts, C. Ronald Kahn, diabetes, Louisville

MicroBiome Therapeutics: Diabetes drug effect enhanced in combination with company's test drugs

MicroBiome Therapeutics: Diabetes drug effect enhanced in combination with company's test drugs

BROOMFIELD - MicroBiome Therapeutics LLC today reported a recently published scientific study shows the diabetes drug, metformin, alters the bacterial populations in the gut in favor of a... Read More

By: InnovatioNews Tuesday June 17, 2014 0 comments Tags: Broomfield, diabetes, metformin, Steve Orndorff

CSU researchers study deadly link between TB and diabetes, seek dual occurrence treatment

CSU researchers study deadly link between TB and diabetes, seek dual occurrence treatment

FORT COLLINS - Research at Colorado State University has revealed new links between tuberculosis and diabetes, providing evidence that TB becomes more deadly when it occurs with diabetes and... Read More

By: InnovatioNews Monday June 9, 2014 0 comments Tags: Brendan Podell, CSU, diabetes, Fort Collins, Randall Basaraba, tuberculosis